Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
Idioma
en
Article de revue
Este ítem está publicado en
Eur.J.Nucl.Med.Mol.Imaging. 2017, vol. 44, n° 6, p. 1095-1096
Resumen en inglés
Letter about the article by Sansovini et al. “Sansovini M, Severi S, Ianniello A, Nicolini S, Fantini L, Mezzenga E, Ferroni F, Scarpi E, Monti M, Bongiovanni A, Cingarlini S, Grana CM, Bodei L, Paganelli G. Long-term ...Leer más >
Letter about the article by Sansovini et al. “Sansovini M, Severi S, Ianniello A, Nicolini S, Fantini L, Mezzenga E, Ferroni F, Scarpi E, Monti M, Bongiovanni A, Cingarlini S, Grana CM, Bodei L, Paganelli G. Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-DOTATATE. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499.”< Leer menos
Orígen
Importado de Hal